Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Spokane. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Spokane at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically applied IDP-122 lotion in pediatric participants with moderate to severe plaque psoriasis.
Sponsor: Bausch Health Americas, Inc.
Check if you qualify for this plaque psoriasis clinical trial in Spokane, WA
If you're searching for plaque psoriasis treatment options in Spokane, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Spokane research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.